Severe COVID-19 infection in a child receiving immunotherapy for cancer

Pediatr Blood Cancer. 2021 Mar;68(3):e28710. doi: 10.1002/pbc.28710. Epub 2020 Sep 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 / therapy*
  • Child
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / adverse effects*
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunologic Factors / adverse effects*
  • Immunologic Factors / therapeutic use
  • Immunotherapy / adverse effects*
  • Immunotherapy / methods
  • Infant
  • Neuroblastoma / drug therapy*
  • SARS-CoV-2 / drug effects

Substances

  • Immunologic Factors
  • Granulocyte-Macrophage Colony-Stimulating Factor